Transplant News and Research

RSS

Diverse group of researchers to address eye healthcare problems of the 21st century

For an individual the loss of sight is estimated by the RNIB to have a financial impact of -20k per year and the annual cost to the UK economy is around -6.5 billion in terms of direct healthcare costs and other costs such as unpaid carers and loss of employment.

3 Jun 2014

Older, obese women with diabetes and on dialysis at risk for calciphylaxis

Obese, Caucasian females over age 50 with diabetes and on dialysis because their kidneys have failed are among those at highest risk for the rare and deadly condition calciphylaxis, according to an analysis of the United States Renal Data System.

3 Jun 2014

Ibrutinib outperforms ofatumumab as second-line therapy for CLL treatment

In a head-to-head comparison of two Food and Drug Administration-approved drugs for the treatment of relapsed chronic lymphocytic leukemia (CLL), ibrutinib significantly outperformed ofatumumab as a second-line therapy, according to a multicenter interim study published in the OnLine First edition of the New England Journal of Medicine.

2 Jun 2014

New cancer panel holds promise in detection of previously undetected viral, cancer mutations

Researchers from Sanford Health and Chronix Biomedical today announced that results from a pilot study demonstrating the utility of a new cancer panel to detect previously undetected viral and cancer mutations are to be reported in a poster presentation titled "Detection of novel HPV mutations and chromosomal number imbalance (CNI) in oropharyngeal and laryngeal cancer using next-generation sequencing (NGS)" (Abstract #6072) at the American Society of Clinical Oncology Annual Meeting (ASCO 2014) being held from May 30 through June 3, 2014 in Chicago.

31 May 2014

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

Promedior, Inc., today announced positive preliminary data from its Phase 2 trial of PRM-151, an anti-fibrotic immunotherapy, in patients with myelofibrosis which demonstrated biologic activity with improvements across clinically relevant measures, including bone marrow fibrosis, hemoglobin, platelets, spleen, and symptoms.

31 May 2014

Researchers make headway in fabricating blood vessels using 3D bioprinting technique

The tangled highway of blood vessels that twists and turns inside our bodies, delivering essential nutrients and disposing of hazardous waste to keep our organs working properly has been a conundrum for scientists trying to make artificial vessels from scratch.

31 May 2014

Tai Chi intervention offers anti-aging benefits, says study

Tai Chi, a traditional Chinese martial art and sport, has been found to be beneficial in raising the numbers of an important type of cell when three groups of young people were tested to discover the benefits of Tai Chi, brisk walking or no exercise.

29 May 2014

Patrys reports positive results from PAT-SM6 clinical trial in patients with multiple myeloma

Patrys Limited, a clinical stage biotechnology company, is pleased to announce the clinical results from a patient treated with PAT-SM6 in combination with other marketed multiple myeloma drugs.

28 May 2014

Estrogen therapy and venlafaxine treatment effective for hot flashes, night sweats

A new research study from Brigham and Women's Hospital (BWH) that compares low-dose oral estrogen and low-dose non-hormonal venlafaxine hydrochloride extended release (XR) to placebo were both found effective in reducing the number of hot flashes and night sweats reported by menopausal women.

27 May 2014

Longer looks: How doctors treat patients; myths about Obamacare; curing cancer

Many years ago I spent a lunch hour in a doctors' dining room eavesdropping on two white-coated men of a certain age idly discussing a colleague who worked at the city hospital next door.

23 May 2014

EKF affirms that novel sTNFR1/2 biomarkers can help predict end-stage renal disease

EKF, confirms scientific evidence as validation that soluble TNF Receptors 1 and 2 are strong biomarkers of progressive Diabetic Kidney Disease.

From EKF Diagnostics 23 May 2014

Kidney transplant recipients live longer than patients on intensive home hemodialysis

A first-ever study from a large Canadian centre found that kidney transplant recipients lived longer and had better treatment success than patients on intensive home hemodialysis, but also had an increased risk of being hospitalized within the first year.

23 May 2014

Nationwide Children's Hospital offers Meta-iodobenzylguanidine therapy for neuroblastoma

Meta-iodobenzylguanidine (MIBG) therapy is now offered by Hematology/Oncology/Blood and Marrow Transplant at Nationwide Children's Hospital. Patients with neuroblastoma who qualify for treatment with MIBG therapy can be treated in this new facility, with round-the-clock supervision by specially trained staff through video and audio monitoring.

21 May 2014

Online educational game among medical professionals can improve health measures of patients

Primary care providers who engaged in an online game to solve clinical cases about hypertension management improved blood pressure control of their patients in a shorter amount of time compared to non-gamers, according to a new study by researchers at Brigham and Women's Hospital (BWH) and the Veterans Affairs Boston Healthcare System.

21 May 2014

SynCardia Total Artificial Heart achieves 1,300th milestone

SynCardia Systems, Inc. announced today that a United States patient with end-stage biventricular heart failure received the 1,300th implant of the SynCardia temporary Total Artificial Heart as a bridge to transplant in April 2014.

20 May 2014

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

RNA interference (RNAi) is a naturally occurring process, which cells can use to silence, or ‘turn off’ unwanted genes.

From Quest Diagnostics 19 May 2014

Walking shown to improve clinical outcomes in patients with kidney disease

A recent study indicates that walking can reduce the risks of premature death and the need for dialysis or kidney transplant among patients with kidney disease.

16 May 2014

Promedior to present interim data from PRM-151 Phase 2 trial at ASCO 2014 Annual Meeting

Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that principal investigator, Srdan Verstovsek, MD, PhD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 2, 2014 at the American Society for Clinical Oncology 2014 Annual Meeting.

15 May 2014

Fourteen businesses receive innovative funding to improve kidney care

NEW ideas and technologies that could prevent kidney disease, allow earlier diagnosis and give patients greater independence are to be developed thanks to an innovative funding competition developed.

From Randox Laboratories Ltd. 15 May 2014

Baylor receives patent for islet cell transplantation in patients with type1 diabetes, chronic pancreatitis

Baylor Research Institute has been awarded a patent from the U.S. Patent Office for a potential strategy to improve the outcomes of islet cell transplantation for patients with type 1 diabetes and chronic pancreatitis.

14 May 2014

Transplant News and Research

Diverse group of researchers to address eye healthcare problems of the 21st century

Older, obese women with diabetes and on dialysis at risk for calciphylaxis

Ibrutinib outperforms ofatumumab as second-line therapy for CLL treatment

New cancer panel holds promise in detection of previously undetected viral, cancer mutations

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

Researchers make headway in fabricating blood vessels using 3D bioprinting technique

Tai Chi intervention offers anti-aging benefits, says study

Patrys reports positive results from PAT-SM6 clinical trial in patients with multiple myeloma

Estrogen therapy and venlafaxine treatment effective for hot flashes, night sweats

Longer looks: How doctors treat patients; myths about Obamacare; curing cancer

EKF affirms that novel sTNFR1/2 biomarkers can help predict end-stage renal disease

Kidney transplant recipients live longer than patients on intensive home hemodialysis

Nationwide Children's Hospital offers Meta-iodobenzylguanidine therapy for neuroblastoma

Online educational game among medical professionals can improve health measures of patients

SynCardia Total Artificial Heart achieves 1,300th milestone

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

Walking shown to improve clinical outcomes in patients with kidney disease

Promedior to present interim data from PRM-151 Phase 2 trial at ASCO 2014 Annual Meeting

Fourteen businesses receive innovative funding to improve kidney care

Baylor receives patent for islet cell transplantation in patients with type1 diabetes, chronic pancreatitis

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News